Clinical Trials

25 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06337552 2026-05-26

High-Fermented Food Intervention Among Locally Advanced Rectal Cancer Patients (The FEED Trial)

39 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Rectal Neoplasms

NCT03527108 2026-05-22

Nivolumab Plus Ramucirumab in Patients With Recurrent, Advanced, Metastatic NSCLC

36 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03786692 2026-05-22

Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC

107 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02696993 2026-05-20

Nivolumab and Radiation Therapy With or Without Ipilimumab in Treating Patients With Brain Metastases From Non-small Cell Lung Cancer

80 enrolled

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT04015778 2026-05-20

A Exploratory Study of Nivolumab Monotherapy or in Combination With Nab-paclitaxel and Carboplatin in Early Stage NSCLC in China

316 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07596433 2026-05-19

Tumor-informed MRD for Non-small Cell Lung Cancer

450 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04032418 2026-05-18

Pembrolizumab Every 12 Weeks Versus Every 3 Weeks in Treating Patients With Non-small Cell Lung Cancer

9 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03611738 2026-05-15

Ceritinib Plus Docetaxel in ALK-Negative, EGFR WT Advanced NSCLC

21 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02998567 2026-05-12

HyPeR

60 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07485179 2026-05-12

Emulation of the KEYNOTE-042 (NCT02220894) Trial Using Specialty Oncology Electronic Health Records Databases

770 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07581379 2026-05-12

PLuS2

1,826 enrolled

Carcinoma, Non-Small-Cell Lung, Disease, Lung Neoplasms

NCT04716946 2026-05-11

Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy

13 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04940936 2026-05-11

Shared Decision Making on Radiation Dose for Lung Malignancies

40 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Radiation Injuries

NCT03202940 2026-05-08

A Phase IB/II Study of Alectinib Combined With Cobimetinib in Advanced ALK-Rearranged (ALK+) NSCLC

16 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02417662 2026-05-06

SARON

140 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04791839 2026-05-06

Safety and Efficacy of Zimberelimab (AB122) in Combination With Domvanalimab (AB154) and Etrumadenant (AB928) in Patients With Previously Treated Non-Small Cell Lung Cancer

30 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04430725 2026-05-05

Microwave Ablation or Wedge Resection for the Treatment of Lung, Sarcoma and Colorectal Lesions, ALLUME Study

GastrointestinalSarcomaThoracic

74 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Sarcoma, Colorectal Neoplasms

NCT04564157 2026-05-05

NADIM-ADJUVANT

Phase 3 Active not recruiting

210 enrolled

Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

NCT05012254 2026-05-05

NIVIPI-Brain

71 enrolled

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms

NCT05138900 2026-05-05

A Pilot Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) in Central Non-Small Cell Lung Cancer

30 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01888601 2026-05-04

TRACERx

814 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05491811 2026-05-04

EAGLE

47 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03838159 2026-04-30

NADIMII

90 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04073745 2026-04-30

Single Fraction Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Non-small Cell Lung Cancer

50 enrolled

Margins of Excision, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02495896 2026-04-29

Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors

GastrointestinalHead & NeckThoracic

61 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Gallbladder Neoplasms, Pancreatic Neoplasms

NCT03122717 2026-04-29

Osimertinib and Gefitinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer

48 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03586453 2026-04-29

Osimertinib In EGFR Mutant Lung Cancer

30 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04222335 2026-04-29

LUNG-RESIST

80 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06300424 2026-04-29

NEOVADE

32 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07552532 2026-04-27

Multimodal CT-Based Risk Stratification for Postoperative Local Recurrence in NSCLC: A Multicenter Study

2,000 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03969823 2026-04-24

Whole Genomic Landscape of Advanced EGFR-mutant NSCLC

148 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05782361 2026-04-24

POTENT

19 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05882513 2026-04-24

Serplulimab Combined With Chemotherapy in Patients With Resectable Non-small-cell Lung Cancer

36 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05415358 2026-04-22

Immune Signature Analysis of Disease Progression in Post Immunotherapy Lung Cancer Patients

23 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03909334 2026-04-17

Study of Osimertinib With and Without Ramucirumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

160 enrolled

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT07537556 2026-04-17

RATS_RYC

150 enrolled

Carcinoma, Non-Small-Cell Lung, Solitary Pulmonary Nodule, Lung Neoplasms

NCT03110978 2026-04-16

Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer

Phase 2/3 Active not recruiting

140 enrolled

EndocrineThoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Carcinoma, Neuroendocrine

NCT03637816 2026-04-15

Anamorelin Hydrochloride in Reducing Anorexia in Patients With Advanced Non-small Cell Lung Cancer

25 enrolled

Anorexia, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03731585 2026-04-15

Online Psychosocial Intervention in Improving Social Well-Being and Support in Women With Stage I-IV Non-small Cell Lung Cancer Undergoing Treatment

70 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05616624 2026-04-15

ADI-PEG 20 in Combination With Gemcitabine and Docetaxel After Progression on Frontline Therapy in Non-small Cell and Small Cell Lung Cancers

31 enrolled

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT05553834 2026-04-13

PCSK9 Inhibitor and PD-1 Inhibitor in Patients With Metastatic, Refractory To Prior Anti PD-1 Non-small Cell Lung

60 enrolled

Phase 4 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT06282874 2026-04-09

Lorlatinib in Patients With ALK-Positive NSCLC With Brain or Leptomeningeal Metastases

41 enrolled

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

NCT05183932 2026-04-07

SORT

446 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03410043 2026-04-06

Osimertinib, Surgery, and Radiation Therapy in Treating Patients With Stage IIIB or IV Non-small Cell Lung Cancer With EGFR Mutations, NORTHSTAR Study

173 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05703269 2026-04-06

HYPOGRYPHE

BreastCNSDermatologicGenitourinaryThoracic

58 enrolled

Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Small Cell Lung Carcinoma

NCT05242965 2026-04-03

A Multiple Antigen Vaccine (STEMVAC) for the Treatment of Patients With Stage IV Non-Small Cell Lung Cancer

5 enrolled 8 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03377023 2026-04-02

Phase I/II Study of Nivolumab and Ipilimumab Combined With Nintedanib in Non Small Cell Lung Cancer

66 enrolled 17 charts

Carcinoma, Non-Small-Cell Lung

NCT04245514 2026-04-02

Multimodality Treatment in Stage III Non-small Cell Lung Cancer (NSCLC)

90 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03433469 2026-03-30

Osimertinib in Treating Participants With Stage I-IIIA EGFR-mutant Non-small Cell Lung Cancer Before Surgery

27 enrolled 14 charts